产品介绍 评论(0)
宿主来源
Rabbit抗原名称
Phospho-PLK1 (Thr210)分子别名
Serine/threonine-protein kinase PLK1; Polo-like kinase 1 (PLK-1); Serine/threonine-protein kinase 13 (STPK13); PLK; PLK1细胞定位
Cytoskeleton, Nucleus, CytoplasmAccession
P53350克隆号
S-4984抗体类型
Recombinant mAb抗体同种型
IgG反应种属 ?
Hu阳性样本
Thymidine and nocodazole treated HT-29, thymidine and nocodazole treated HeLa纯化方式
Protein A浓度
0.5 mg/ml标记
Unconjugated性状
Liquid缓冲体系
PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
储存条件
12 months from date of receipt / reconstitution, -20 °C as supplied
应用
WB
稀释度
应用 稀释度 推荐种属 WB 1:500-1:1000 Hu
Phospho-PLK1 (Thr210) refers to the activated state of Polo-like kinase 1 following phosphorylation at the critical threonine 210 residue within its activation loop (T-loop), a modification widely recognized as the key molecular switch that drives PLK1 kinase activity. During cell cycle progression, Thr210 is primarily phosphorylated by Aurora A kinase and its cofactor Bora, a process further assisted by adaptor proteins such as WAC to facilitate proper mitotic entry. The phosphorylation level of Thr210 is tightly regulated: this modification is elevated during normal mitosis, but upon DNA damage, protein phosphatase 2A (PP2A) is recruited to remove the phosphate group from Thr210, thereby inhibiting PLK1 activity to arrest the cell cycle and initiate repair mechanisms. Functional studies have shown that the phosphomimetic T210D mutation, which results in sustained phosphorylation at this site, significantly enhances PLK1 kinase activity and leads to mitotic delay or arrest. Therefore, detecting the phosphorylation status of Thr210 (e.g., using the specific antibody #9062) is widely employed as a readout of PLK1 activity and holds significant value in cancer biology and cell cycle research.
免疫印迹
WB result of Phospho-PLK1 (Thr210) Recombinant Rabbit mAb
Blocking/Diluting buffer and concentration: 5% NFDM/TBST
Primary antibody incubation conditions: overnight at 4°C
Primary antibody: Phospho-PLK1 (Thr210) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated HT-29 whole cell lysate 20 µg
Lane 2: HT-29 treated with 2 mM thymidine for 16 hours, then 100 ng/ml Nocodazole for 24 hours whole cell lysate 20 µg
Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 68 kDa
Observed MW: 68 kDa
This blot was developed with high sensitivity substrateWB result of Phospho-PLK1 (Thr210) Recombinant Rabbit mAb
Blocking/Diluting buffer and concentration: 5% NFDM/TBST
Primary antibody incubation conditions: overnight at 4°C
Primary antibody: Phospho-PLK1 (Thr210) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated HeLa whole cell lysate 20 µg
Lane 2: HeLa treated with 2 mM thymidine for 16 hours, then 100 ng/ml Nocodazole for 24 hours whole cell lysate 20 µg
Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 68 kDa
Observed MW: 68 kDa







评论(0)